Previous 10 | Next 10 |
Nevro Announces Participation In Upcoming Investor Conferences PR Newswire REDWOOD CITY, Calif. , Aug. 9, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the...
Nevro Corp. (NVRO) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Julie Dewey - Corporate Communications & IR Officer Keith Grossman - Chairman, President & CEO Roderick MacLeod - CFO Conference Call Participants ...
The following slide deck was published by Nevro Corp. in conjunction with their 2022 Q2 earnings call. For further details see: Nevro Corp. 2022 Q2 - Results - Earnings Call Presentation
Nevro press release ( NYSE: NVRO ): Q2 GAAP EPS of -$0.71 beats by $0.09 . Revenue of $104.21M (+1.8% Y/Y) misses by $0.26M . Sees FY 2022 revenue of $400 million to $410 million vs. prior guidance of about $415M to $430M. The consensus revenue ...
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance PR Newswire REDWOOD CITY, Calif. , Aug. 3, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), delivering comprehensive, life-ch...
Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations PR Newswire Parties Reach an Agreement that Concludes Outstanding Intellectual Property Disputes REDWOOD CITY, Calif. , Aug. 1, 2022 /PRNews...
Cryoport has done well to grow its top line in recent years and some bottom line figures have also fared well. Growth is expected to continue this year, but this doesn't make the company a wise investment. Shares look very expensive right now and are unlikely to offer material ups...
Nevro to Present at the Canaccord Genuity 42nd Annual Growth Conference PR Newswire Wednesday, August 10, 2022 at 2:30 pm Eastern Time REDWOOD CITY, Calif. , July 21, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical...
Nevro to Report Second Quarter 2022 Financial Results PR Newswire Company to Host Conference Call on Wednesday, August 3, 2022 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif. , July 6, 2022 /PRNewswire/ -- Nevro Corp. (...
Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation Therapy PR Newswire High-Frequency 10 kHz Therapy Provided Substant...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...